ArticleOncotarget2017

BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy.

Mingxing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.